Novel nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial disease
刺激外周动脉疾病治疗性血管生成的新型纳米颗粒
基本信息
- 批准号:10756875
- 负责人:
- 金额:$ 5.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-02 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdhesionsAdhesivenessAdhesivesAffectAffinityAmericanAngioplastyAnilineAreaArterial InjuryArteriesAwardBalloon AngioplastyBindingBiological AvailabilityBlood VesselsBlood flowCD34 geneCell ProliferationCharacteristicsCirculationComplementary DNACytoprotectionDataDevelopmentDisease ManagementDopamineDrug Delivery SystemsDrug MonitoringEndothelial CellsEndotheliumEnsureErythropoietin ReceptorEvaluationFamily suidaeFormulationFosteringGoalsHyaluronic AcidHydrogelsIn VitroInflammatory ResponseInvestigationIschemiaLegLigandsMembraneMentorsModalityModelingMusselsNanotechnologyObstructionP-SelectinParentsPatientsPeripheral arterial diseasePharmaceutical PreparationsPlasmidsPolymersProceduresRecoveryResearchResearch PersonnelSiteStandardizationStressSystemTechniquesTestingTherapeuticTherapeutic AgentsTimeTissuesTreatment EffectivenessUnderrepresented MinorityVascular DiseasesVascularizationWorkaging populationangiogenesisantibody conjugatebiomaterial compatibilitycareer developmentcontrolled releasedesigndisadvantaged backgrounddoctoral studentendothelial stem cellequity, diversity, and inclusionfluorescence imagingfucoidanhealingimage guidedimaging capabilitiesimaging modalityimprovedinjuredinnovationlocal drug deliveryminority studentnanocompositenanoparticlenanoparticle deliverynoveloverexpressionparent grantphotoacoustic imagingphysically handicappedrecruitsystemic toxicitytherapeutic angiogenesistherapeutic effectivenessunderrepresented minority student
项目摘要
Abstract
The long-term goal of our parent grant award is to develop novel biocompatible and biodegradable dual-modal
imaging nanoparticles (DINPs) to provide cell protection and to facilitate therapeutic angiogenesis under stress
conditions such as ischemia for peripheral arterial disease (PAD). For this supplement application, we propose
the following approaches aimed to enrich the potential of our parent award: a) the development of fucoidan (FC)
targeted nanoparticles (FC-DINPs) with optimized fluorescent and photoacoustic imaging capabilities, b) the
formulation of FC-DINP loaded hydrogel angioplasty balloon coatings for simultaneous percutaneous
transluminal angioplasty and local drug delivery, and c) the evaluation of FC-DINPs transfer efficacy to ex-vivo
segments of porcine arteries. The main innovative aspects of our design are: 1) the simultaneous angioplasty
treatment and local delivery of therapeutic agents via a mussel-inspired nanocomposite balloon coating formed
by the combination of FC-DINPs and adhesive hydrogels, to ensure a homogeneous and controlled drug
delivery, 2) the use of biodegradable photoluminescent polymer-aniline tetramers (BPLPAT) to fabricate FC-
DINPs, 3) the use of fucoidan (FC), a high affinity targeting ligand for P-selectin overexpressed on injured
endothelium, to improve FC-DINPs attachment to the target site, and 4) the use of HA-DA, an adhesive hydrogel
synthesized with hyaluronic acid (HA) and dopamine (DA), to mimic the adhesive strategies of blue mussels and
to confer the characteristics needed to deliver FC-DINPs from the vehicle and gain adhesion to the inner blood
vessel wall. Furthermore, this proposal focuses on promoting diversity, equity, inclusion, and accessibility (DEIA).
Our proposed research approaches for the treatment of PAD are within the scope of the parent grant (“Novel
nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial disease”) and will help to foster the
research career development of Ms. Ingrid D. Guerrero Rodriguez, a doctoral student from underrepresented
minorities (URM) with a disadvantaged background and a physical disability. She will be mentored and supported
by the PI, Dr. Kytai T. Nguyen, a researcher and educator with a proven record of her commitment to the
advancement of minority students in STEM.
抽象的
我们的家长资助奖的长期目标是开发新型生物相容性和可生物降解的双模式
成像纳米粒子(DINP)提供细胞保护并促进应激下的治疗性血管生成
外周动脉疾病(PAD)引起的缺血等疾病。对于此补充申请,我们建议
以下方法旨在丰富我们母奖的潜力:a) 岩藻依聚糖 (FC) 的开发
具有优化的荧光和光声成像能力的靶向纳米粒子(FC-DINP),b)
用于同步经皮的负载 FC-DINP 的水凝胶血管成形球囊涂层的配方
腔内血管成形术和局部药物递送,以及 c) FC-DINP 体外转移功效的评估
猪动脉的片段。我们设计的主要创新点是:1)同步血管成形术
通过形成的受贻贝启发的纳米复合材料球囊涂层进行治疗和局部递送治疗剂
通过 FC-DINP 和粘性水凝胶的结合,以确保均匀且受控的药物
交付,2)使用可生物降解的光致发光聚合物苯胺四聚体(BPLPAT)来制造FC-
DINP,3) 使用岩藻依聚糖 (FC),这是一种高亲和力靶向配体,用于在损伤部位过表达的 P-选择素
内皮细胞,以改善 FC-DINP 对目标位点的附着,以及 4) 使用 HA-DA(一种粘性水凝胶)
由透明质酸 (HA) 和多巴胺 (DA) 合成,模仿蓝贻贝的粘附策略
赋予从载体输送 FC-DINP 所需的特性并获得对内部血液的粘附
血管壁。此外,该提案的重点是促进多样性、公平性、包容性和可及性(DEIA)。
我们提出的治疗 PAD 的研究方法属于母基金的范围(“Novel
纳米颗粒刺激外周动脉疾病的治疗性血管生成”),并将有助于促进
来自弱势群体的博士生 Ingrid D. Guerrero Rodriguez 女士的研究职业发展
具有弱势背景和身体残疾的少数群体 (URM)。她将得到指导和支持
由 PI Kytai T. Nguyen 博士负责,她是一位研究员和教育家,她对
少数民族学生在 STEM 方面的进步。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RALPH P. MASON其他文献
RALPH P. MASON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RALPH P. MASON', 18)}}的其他基金
Novel nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial disease
刺激外周动脉疾病治疗性血管生成的新型纳米颗粒
- 批准号:
10462909 - 财政年份:2022
- 资助金额:
$ 5.97万 - 项目类别:
Novel nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial disease
刺激外周动脉疾病治疗性血管生成的新型纳米颗粒
- 批准号:
10616740 - 财政年份:2022
- 资助金额:
$ 5.97万 - 项目类别:
Vascular image-guided optimization of response (VIGOR) to therapy in kidney cancer
血管图像引导肾癌治疗反应优化 (VIGOR)
- 批准号:
10646312 - 财政年份:2020
- 资助金额:
$ 5.97万 - 项目类别:
Vascular image-guided optimization of response (VIGOR) to therapy in kidney cancer
血管图像引导肾癌治疗反应优化 (VIGOR)
- 批准号:
10442463 - 财政年份:2020
- 资助金额:
$ 5.97万 - 项目类别:
Vascular image-guided optimization of response (VIGOR) to therapy in kidney cancer
血管图像引导肾癌治疗反应优化 (VIGOR)
- 批准号:
10058644 - 财政年份:2020
- 资助金额:
$ 5.97万 - 项目类别:
Vascular image-guided optimization of response (VIGOR) to therapy in kidney cancer
血管图像引导肾癌治疗反应优化 (VIGOR)
- 批准号:
10171568 - 财政年份:2020
- 资助金额:
$ 5.97万 - 项目类别:
PROGNOSTIC RADIOLOGY AND THE PATHOPHYSIOLOGY OF TUMORS
预后放射学和肿瘤病理生理学
- 批准号:
8363897 - 财政年份:2011
- 资助金额:
$ 5.97万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 5.97万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 5.97万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 5.97万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 5.97万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 5.97万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 5.97万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 5.97万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 5.97万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 5.97万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 5.97万 - 项目类别:














{{item.name}}会员




